Skip to Content

Join the 'Lymphoma' group to help and get support from people like you.

Lymphoma News

Related terms: Cancer, Lymphoma

FDA Approves Copiktra (duvelisib) Capsules for Chronic Lymphocytic Leukemia/Small Lymphocytic Lymphoma and Follicular Lymphoma

Posted 23 hours ago by Drugs.com

BOSTON--(BUSINESS WIRE)--Sep. 24, 2018-- Verastem, Inc. (Nasdaq:VSTM) (Verastem Oncology or the Company), focused on developing and commercializing medicines to improve the survival and quality of life of cancer patients, today announced that the U.S. Food and Drug Administration (FDA) has approved Copiktra, an oral inhibitor of phosphoinositide 3-kinase (PI3K), and the first approved dual ...

Blood Test Gives Quick Prognosis for Lymphoma Treatment: Study

Posted 21 Aug 2018 by Drugs.com

TUESDAY, Aug. 21, 2018 – A blood test can predict which lymphoma patients will respond well to normal treatment and which may need a more aggressive approach, researchers report. Their study included 217 patients with diffuse large B cell lymphoma, the most common type of the blood cancer non-Hodgkin lymphoma. The blood test checks levels of circulating tumor DNA (ctDNA) in patients before and ...

Were NYC Cancer Cases Tied to Chernobyl Disaster?

Posted 22 Jan 2018 by Drugs.com

MONDAY, Jan. 22, 2018 – A possible link between a cluster of cases in New York City of an extremely rare type of cancer and the 1986 Chernobyl nuclear plant disaster in Ukraine has been found by researchers. They began their investigation after 10 people in New York City were diagnosed with vitreoretinal lymphoma (VRL) in a four-year span. VRL affects the eyes and can occur in people with a rare ...

Get Active, Beat Lymphoma?

Posted 12 Dec 2017 by Drugs.com

TUESDAY, Dec. 12, 2017 – Physical activity appears to help people with lymphoma survive their disease. That finding comes from a new study by Mayo Clinic researchers of nearly 4,100 people with lymphoma, a cancer that starts in the white blood cells that normally help fight infection. "As physicians, we recommend physical activity for all cancer survivors to improve overall quality of life, but ...

Seattle Genetics Announces FDA Approval of Adcetris (Brentuximab Vedotin) for Primary Cutaneous Anaplastic Large Cell Lymphoma (pcALCL) and CD30-Expressing Mycosis Fungoides (MF)

Posted 27 Nov 2017 by Drugs.com

BOTHELL, Wash.--(BUSINESS WIRE)--Nov. 9, 2017-- Seattle Genetics, Inc. (Nasdaq: SGEN) announced today that the U.S. Food and Drug Administration (FDA) has approved Adcetris (brentuximab vedotin) for the treatment of adult patients with primary cutaneous anaplastic large cell lymphoma (pcALCL) and CD30-expressing mycosis fungoides (MF) who have received prior systemic therapy. Primary cutaneous ...

FDA Approves Genentech’s Gazyva for Previously Untreated Advanced Follicular Lymphoma

Posted 23 Nov 2017 by Drugs.com

South San Francisco, CA – November 16, 2017 – Genentech, a member of the Roche Group (SIX: RO, ROG; OTCQX: RHHBY), announced today that the U.S. Food and Drug Administration (FDA) approved Gazyva (obinutuzumab) in combination with chemotherapy, followed by Gazyva alone in those who responded, for people with previously untreated advanced follicular lymphoma (stage II bulky, III or IV). The ...

FDA Approves Calquence (acalabrutinib) for Adults with Mantle Cell Lymphoma

Posted 31 Oct 2017 by Drugs.com

October 31, 2017 – The U.S. Food and Drug Administration today granted accelerated approval to Calquence (acalabrutinib) for the treatment of adults with mantle cell lymphoma who have received at least one prior therapy. “Mantle cell lymphoma is a particularly aggressive cancer,” said Richard Pazdur, M.D., director of the FDA’s Oncology Center of Excellence and acting director of the Office of He ...

Calquence Approved for Mantle Cell Lymphoma

Posted 31 Oct 2017 by Drugs.com

TUESDAY, Oct. 31, 2017 – Calquence (acalabrutinib) has been approved by the U.S. Food and Drug Administration to treat adults with mantle cell lymphoma. Mantle cell is an aggressive, fast-growing non-Hodgkin lymphoma, a cancer of the lymph system. Though it represents only 3 percent to 10 percent of non-Hodgkin cases in the United States, the cancer usually has spread by the time it's detected, ...

Calquence Approved for Mantle Cell Lymphoma

Posted 31 Oct 2017 by Drugs.com

TUESDAY, Oct. 31, 2017 – Calquence (acalabrutinib) has been approved by the U.S. Food and Drug Administration to treat adults with mantle cell lymphoma. Mantle cell is an aggressive, fast-growing non-Hodgkin lymphoma, a cancer of the lymph system. Though it represents only 3 percent to 10 percent of non-Hodgkin cases in the United States, the cancer usually has spread by the time it's detected, ...

Textured Breast Implants Linked to Rare Cancer

Posted 20 Oct 2017 by Drugs.com

FRIDAY, Oct. 20, 2017 – A particular breast implant may be associated with a rare type of cancer, researchers report. Breast implant-associated anaplastic large cell lymphoma (BIA-ALCL) is estimated to affect 1 in 30,000 women each year, but researchers said it may actually be more common. "We're seeing that this cancer is likely very underreported, and as more information on this type of cancer ...

FDA Approves Yescarta (axicabtagene ciloleucel) CAR-T Cell Therapy to Treat Adults with Certain Types of Large B-Cell Lymphoma

Posted 19 Oct 2017 by Drugs.com

October 18, 2017 – The U.S. Food and Drug Administration today approved Yescarta (axicabtagene ciloleucel), a cell-based gene therapy, to treat adult patients with certain types of large B-cell lymphoma who have not responded to or who have relapsed after at least two other kinds of treatment. Yescarta, a chimeric antigen receptor (CAR) T cell therapy, is the second gene therapy approved by the ...

Newer Drug May Prolong Lymphoma Remission

Posted 5 Oct 2017 by Drugs.com

WEDNESDAY, Oct. 4, 2017 – A newer drug may beat the standard treatment when it comes to battling the blood cancer follicular lymphoma, a clinical trial suggests. Follicular lymphoma is one type of non-Hodgkin lymphoma, a group of cancers that arise in white blood cells. The new study found that a drug called obinutuzumab (Gazyva) typically kept the cancer under control longer, versus the ...

Adding Rituximab to Standard Care May Prolong Lymphoma Survival

Posted 28 Sep 2017 by Drugs.com

WEDNESDAY, Sept. 27, 2017 – Long-term treatment with the drug rituximab (Rituxan) may extend the lives of some patients with a rare form of blood cancer, a new clinical trial finds. The disease, known as mantle-cell lymphoma, is generally incurable. But various treatments can prolong people's lives. Some patients, for instance, are able to undergo chemotherapy to wipe out the cancer cells, ...

FDA Approves Aliqopa (copanlisib) for Adults with Relapsed Follicular Lymphoma

Posted 17 Sep 2017 by Drugs.com

September 14, 2017 – The U.S. Food and Drug Administration today granted accelerated approval to Aliqopa (copanlisib) for the treatment of adults with relapsed follicular lymphoma who have received at least two prior treatments known as systemic therapies. “For patients with relapsed follicular lymphoma, the cancer often comes back even after multiple treatments,” said Richard Pazdur, M.D., dir ...

Aliqopa Approved for Follicular Lymphoma

Posted 14 Sep 2017 by Drugs.com

THURSDAY, Sept. 14, 2017 – Aliqopa (copanlisib) has been approved by the U.S. Food and Drug Administration to treat adults with relapsed follicular lymphoma who have received at least two prior treatments with certain other drugs. Follicular lymphoma is a slow-growing cancer of the lymph system of the type known as non-Hodgkin lymphoma. More than 72,000 people in the United States are likely to ...

Page 1 2 3 Next

Ask a Question

Further Information

Related Condition Support Groups

Non-Hodgkin's Lymphoma, Hodgkin's Lymphoma, Blood Disorders

Related Drug Support Groups

prednisone, methotrexate, cortisone, dexamethasone, Revlimid, Decadron, Imbruvica, ibrutinib, Deltasone, view more... Velcade, Leukeran, Adriamycin, doxorubicin, Methotrexate LPF Sodium, Dexone, Liquid Pred, Sterapred, Velban, chlorambucil, Ontak, Adrenocot LA, Roferon-A, Adrenocot, brentuximab, vinblastine, thiotepa, Sterapred DS, denileukin diftitox, Prednicot, Cortone Acetate, Prednicen-M, Adriamycin PFS, Dexamethasone Intensol, Thioplex, bortezomib, Baycadron, Folotyn, Dalalone, Dalalone DP, Dalalone LA, Decaject, Decaject LA, Zema Pak, Adcetris, Tepadina, Beleodaq, Zydelig, Zonacort, Orasone, Dexasone LA, Meticorten, Decadron-LA, interferon alfa-2a, lenalidomide, nelarabine, pralatrexate, belinostat, idelalisib, Trexall, Arranon, Folex PFS, Hexadrol, Solurex LA, Adriamycin RDF, Dexacen-4, Solurex, De-Sone LA, Dexacort-LA, Dexasone, Dexone LA, Primethasone, Dexacorten, Medidex, Medidex LA, Dexpak Taperpak, LoCort